Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

Clinical trial NCT05615948 · COMPLETED

Trial details

NCT number: NCT05615948
Sponsor: Theresa Jacob, PhD, MPH
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Treatment Resistant Depression Major Depressive Disorder Analgesia Ketamine Peripheral Nervous System Agents Central Nervous System Depressants Neurotransmitter Agents Anti-Inflammatory Agents Physiological Effects of Drugs Sensory System Agents Analgesics, Non-Narcotic Anti-Inflammatory Agents, Non-Steroidal

Start date: 2022-12-06
Primary completion: 2024-05-17
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.